TY - JOUR
T1 - Personal Activity Intelligence (PAI)
T2 - A new standard in activity tracking for obtaining a healthy cardiorespiratory fitness level and low cardiovascular risk
AU - Nauman, Javaid
AU - Nes, Bjarne M.
AU - Zisko, Nina
AU - Revdal, Anders
AU - Myers, Jonathan
AU - Kaminsky, Leonard A.
AU - Wisløff, Ulrik
N1 - Funding Information:
The study was funded by grants from the Norwegian Research Council , the Liaison Committee between the Central Norway Regional Health Authority and the Norwegian University of Science and Technology . The funding organizations had no role in the design and execution of the study, in the collection, analysis, and interpretation of the data or in the preparation, review, or approval of the manuscript.
Funding Information:
The Nord-Tr?ndelag Health Study (the HUNT Study) is a collaboration between the HUNT Research Centre (Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology NTNU), the Nord-Tr?ndelag County Council, Central Norway Regional Health Authority and the Norwegian Institute of Public Health. We are appreciative of the participants from the HUNT study, and the management of the study for using these data. The study was funded by grants from the Norwegian Research Council, the Liaison Committee between the Central Norway Regional Health Authority and the Norwegian University of Science and Technology. The funding organizations had no role in the design and execution of the study, in the collection, analysis, and interpretation of the data or in the preparation, review, or approval of the manuscript. Professor Wisl?ff is the inventor of PAI, and scientific advisor of a company (PAI Health Inc.) that holds the IP rights for PAI that develops applications that utilize data from diverse heart rate monitors to display PAI for users. Due to the potential conflict of interest, we are thankful to Professor Sigurd Steinshamn at Department of Circulation and Medical Imaging, Faculty of Medicine and Health Sciences, NTNU who monitored adherence to design, and statistical analysis in the current study. We have read and understood the policy of the Progress in Cardiovascular Diseases and declare that design, statistical analyses, and reporting of results of the current study are in accordance with the directives of Regional Committee on Medical and Health Research Ethics of Norway (2017/2425/REK nord). There are no further disclosures or potential conflicts of interest to report.
Publisher Copyright:
© 2019 Elsevier Inc.
PY - 2019/3/1
Y1 - 2019/3/1
N2 - Despite all the evidence of health benefits related to physical activity (PA) and cardiorespiratory fitness (CRF), low levels of PA have reached pandemic proportions, and inactivity is the fourth leading cause of death worldwide. Lack of time, and inability to self-manage are often cited as main barriers to getting adequate PA. Recently, a new personalized metric for PA tracking named Personal Activity Intelligence (PAI) was developed with the aim to make it easier to quantify how much PA per week is needed to reduce the risk of premature mortality from non-communicable diseases. PAI can be integrated in self-assessment heart rate devices and defines a weekly beneficial heart rate pattern during PA by considering the individual's sex, age, and resting and maximal heart rates. Among individuals ranging from the general population to subgroups of patients with cardiovascular disease (CVD), a PAI score ≥100 per week at baseline, an increase in PAI score, and a sustained high PAI score over time were found to delay premature death from CVD and all causes, regardless of whether or not the current PA recommendations were met. Importantly, a PAI score ≥100 at baseline, maintaining ≥100 PAIs and an increasing PAI score over time was associated with multiple years of life gained. Moreover, obtaining a weekly PAI ≥100 attenuated the deleterious association between CVD risk factor clustering and prolonged sitting time. PAI and objectively measured CRF (as indicated by VO 2peak ) were positively associated in a graded fashion, and individuals with a PAI score between 100 and 150 had expected age and sex specific average VO 2peak values. A PAI score ≥100 was associated with higher VO 2peak in both men (4.1 mL·kg −1 ·min −1 ; 95% CI, 3.5 to 4.6) and women (2.9 mL·kg −1 ·min −1 ; 95% CI, 2.4 to 3.3), compared to the reference group of <100 PAI. The combined analysis of PAI, PA and VO 2peak demonstrated that a PAI score ≥100 was associated with high VO 2peak values regardless of meeting or not meeting the current PA recommendations. Collectively, these findings suggest that PAI has the potential to be a useful tool to motivate people to become and stay physically active by quantifying the amount of PA needed to produce significant health benefits.
AB - Despite all the evidence of health benefits related to physical activity (PA) and cardiorespiratory fitness (CRF), low levels of PA have reached pandemic proportions, and inactivity is the fourth leading cause of death worldwide. Lack of time, and inability to self-manage are often cited as main barriers to getting adequate PA. Recently, a new personalized metric for PA tracking named Personal Activity Intelligence (PAI) was developed with the aim to make it easier to quantify how much PA per week is needed to reduce the risk of premature mortality from non-communicable diseases. PAI can be integrated in self-assessment heart rate devices and defines a weekly beneficial heart rate pattern during PA by considering the individual's sex, age, and resting and maximal heart rates. Among individuals ranging from the general population to subgroups of patients with cardiovascular disease (CVD), a PAI score ≥100 per week at baseline, an increase in PAI score, and a sustained high PAI score over time were found to delay premature death from CVD and all causes, regardless of whether or not the current PA recommendations were met. Importantly, a PAI score ≥100 at baseline, maintaining ≥100 PAIs and an increasing PAI score over time was associated with multiple years of life gained. Moreover, obtaining a weekly PAI ≥100 attenuated the deleterious association between CVD risk factor clustering and prolonged sitting time. PAI and objectively measured CRF (as indicated by VO 2peak ) were positively associated in a graded fashion, and individuals with a PAI score between 100 and 150 had expected age and sex specific average VO 2peak values. A PAI score ≥100 was associated with higher VO 2peak in both men (4.1 mL·kg −1 ·min −1 ; 95% CI, 3.5 to 4.6) and women (2.9 mL·kg −1 ·min −1 ; 95% CI, 2.4 to 3.3), compared to the reference group of <100 PAI. The combined analysis of PAI, PA and VO 2peak demonstrated that a PAI score ≥100 was associated with high VO 2peak values regardless of meeting or not meeting the current PA recommendations. Collectively, these findings suggest that PAI has the potential to be a useful tool to motivate people to become and stay physically active by quantifying the amount of PA needed to produce significant health benefits.
KW - Activity tracking
KW - Cardiorespiratory fitness
KW - Cardiovascular disease
KW - Mortality
KW - Physical activity promotion
KW - Prevention
UR - http://www.scopus.com/inward/record.url?scp=85063229069&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85063229069&partnerID=8YFLogxK
U2 - 10.1016/j.pcad.2019.02.006
DO - 10.1016/j.pcad.2019.02.006
M3 - Review article
C2 - 30797801
AN - SCOPUS:85063229069
SN - 0033-0620
VL - 62
SP - 179
EP - 185
JO - Progress in Cardiovascular Diseases
JF - Progress in Cardiovascular Diseases
IS - 2
ER -